Premature atherosclerosis in primary antiphospholipid syndrome: Preliminary data

Annals of the Rheumatic Diseases

Volumn 64, Issue 2, 2005, Pages 315-317

  Ames, P R J ^a   Margarita, A ^c   Sokoll, K B ^a   Weston, M ^b   Brancaccio, V ^c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c CARDARELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; AGE DISTRIBUTION; ANTIPHOSPHOLIPID SYNDROME; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY BIFURCATION; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INTERNAL CAROTID ARTERY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ADULT; AGE FACTORS; ANTIPHOSPHOLIPID SYNDROME; ARTERIOSCLEROSIS; CAROTID ARTERIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 13244278356     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.023952     Document Type: Article

References (14)

1. Ames PRJ. Medical perspective. Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus. A unifying "membrane stress syndrome" hypothesis. Lupus 1994;3:371-7.
2. Svenungsson E, Jensen-Urstad K, Heimburger M, Silveira A, Hamsten A, de Faire U, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001;104:1887-93.
3. Roman MJ, Salmon JE, Sobel R, Lockshin MD, Sammaritano L, Schwartz JE, et al. Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Am J Cardiol 2001;87:663-6.
4. Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999;42:51-60.
5. Biloro F, Boccioletti V, Girolami B, Zanon E, Armani M, Petrobelli F, et al. Are antiphospholipid antibodies an independent risk factor for atherosclerosis? Clin Appl Thromb Hemost 2002;8:103-13.
6. Medina G, Casaos D, Jara LJ, Vera-Lastra O, Fuentes M, Barile L, et al. Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 2003;62:607-10.
7. Nityanand S, Bergmark C, de Faire U, Swedenborg J, Holm G, Lefvert AK. Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. J Intern Med 1995;238:437-43.
8. Glueck CJ, Lang JE, Tracy T, Sieve-Smith L, Wang P. Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease. Am J Cardiol 1999;83:1490-4.
9. Ames PRJ, Margarita A, Delgado Alves J, Tommasino C, Iannaccone L, Brancaccio V. Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies. Lupus 2002;11:208-14.
10. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
11. Greaves M, Cohen H, Machin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000;109:704-15.
12. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1995;26:386-91.
13. Sangle SR, D'Cruz DP, Jan W, Karim MY, Khamashta MA, Abbs IC, et al. Renal artery stenosis in the antiphospholipid syndrome and hypertension. Ann Rheum Dis 2003;62:999-1002.
14. Kuller LW. Ethnic differences in atherosclerosis, cardiovascular disease and lipid metabolism. Curr Opin Lipidol 2004;15:109-13.